Pharmacological reports : PR · 2026
Tetrahydrocurcumin suppresses FcεRI- and MRGPRX2-mediated mast cell activation and attenuates peanut-induced anaphylaxis in an in vitro and in vivo study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suk Gyeongseo, Mun Jiyoon, Park Ji Yeon, Park Minae, Hwang Ee Taek, Choi Hae Woong
Аннотация
BACKGROUND: Tetrahydrocurcumin (THC), a major reductive metabolite of curcumin, possesses improved chemical stability and anti-inflammatory properties. However, its direct effects on mast cell-mediated allergic responses remain poorly defined. We investigated whether THC suppresses FcεRI-dependent and selected IgE-independent mast cell activation and protects against peanut-induced anaphylaxis in vivo.
METHODS: Primary murine bone marrow-derived mast cells and human LAD2 mast cells were stimulated through IgE/FcεRI crosslinking or MRGPRX2-related activation. Mast cell degranulation, cytokine production (CCL2, TNF, IL-6, and IL-13), and cytotoxicity were evaluated. The in vivo efficacy of orally administered THC was assessed in a mouse model of peanut-induced anaphylaxis.
RESULTS: THC dose-dependently inhibited IgE/FcεRI-mediated mast cell degranulation and suppressed inflammatory cytokine production without detectable cytotoxicity. Under the tested conditions, THC exhibited greater inhibitory activity than pemirolast potassium. THC also suppressed ionomycin- and MRGPRX2-mediated mast cell activation and remained effective when administered before or at the initiation of activation. In peanut-sensitized mice, repeated oral THC administration significantly reduced anaphylactic hypothermia and intestinal inflammatory responses.
CONCLUSION: THC suppresses FcεRI-dependent and MRGPRX2-dependent pathways and attenuates peanut-induced anaphylactic responses in vivo. These findings support the potential of THC as a mast cell-modulating compound for allergic and anaphylactic disorders.
METHODS: Primary murine bone marrow-derived mast cells and human LAD2 mast cells were stimulated through IgE/FcεRI crosslinking or MRGPRX2-related activation. Mast cell degranulation, cytokine production (CCL2, TNF, IL-6, and IL-13), and cytotoxicity were evaluated. The in vivo efficacy of orally administered THC was assessed in a mouse model of peanut-induced anaphylaxis.
RESULTS: THC dose-dependently inhibited IgE/FcεRI-mediated mast cell degranulation and suppressed inflammatory cytokine production without detectable cytotoxicity. Under the tested conditions, THC exhibited greater inhibitory activity than pemirolast potassium. THC also suppressed ionomycin- and MRGPRX2-mediated mast cell activation and remained effective when administered before or at the initiation of activation. In peanut-sensitized mice, repeated oral THC administration significantly reduced anaphylactic hypothermia and intestinal inflammatory responses.
CONCLUSION: THC suppresses FcεRI-dependent and MRGPRX2-dependent pathways and attenuates peanut-induced anaphylactic responses in vivo. These findings support the potential of THC as a mast cell-modulating compound for allergic and anaphylactic disorders.